文献速递胃肠动力与功能性疾病

肠脑轴功能障碍是肠易激综合征中FODMAP诱导症状产生的基础

Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-15

这项随机双盲交叉研究在13例肠易激综合征(IBS)患者和13名健康对照中,比较了果聚糖、葡萄糖和生理盐水胃内灌注后的小肠水分、结肠气体及脑部反应。果聚糖在两组中同样增加小肠动力和结肠气体与体积,但IBS患者对果聚糖的症状反应更重,且与疼痛相关脑区反应改变共变,提示肠脑轴失调可能驱动FODMAP诱导的症状产生。

要点

  • 果聚糖在IBS患者和健康对照中同样增加小肠动力和结肠气体与体积。
  • IBS患者对果聚糖的痉挛、疼痛、胀气和恶心症状反应较健康对照更重。
  • IBS患者疼痛相关脑区对果聚糖的反应与症状反应共变,提示肠脑轴失调。

核心结论

  • 果聚糖在IBS患者和健康对照中同样增加小肠动力和结肠气体与体积;IBS患者对果聚糖症状反应增加与疼痛相关脑区反应改变共变,提示肠脑轴失调可能驱动IBS中FODMAP诱导的症状产生。

研究设计与样本

  • 随机双盲交叉研究,共三次访视,每次访视在1小时MR脑扫描期间胃内灌注果聚糖(40 g/500 mL生理盐水)、葡萄糖(40 g/500 mL生理盐水)或生理盐水(500 mL),灌注前、灌注后1小时和2小时行腹部MRI。
  • 研究纳入IBS患者13例和健康对照13名,症状采用经验证的量表评分。

主要发现

  • 在IBS患者(n=13)中,果聚糖较葡萄糖诱发更多痉挛、疼痛、胀气和恶心(P分别为0.03、0.001、0.009和<0.001),健康对照(n=13)中无此差异(所有P>0.14),组间痉挛和恶心差异P分别为0.004和0.023。
  • 果聚糖在IBS患者和健康对照中同样增加小肠动力和升结肠气体与体积(组间P>0.25)。
  • 在IBS患者中,果聚糖与生理盐水之间结肠气体差异与胀气和痉挛差异共变(P分别为0.008和0.035)。
  • 与健康对照相比,IBS患者疼痛相关脑区对果聚糖反应不同,包括小脑、缘上回、前扣带和中扣带皮层、岛叶和丘脑(pFWE校正<0.05);这些脑反应与IBS患者症状反应共变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: FODMAPs produce similar small bowel water and colonic gas in patients with irritable bowel syndrome (IBS) and healthy controls (HCs), despite IBS patients reporting increased gastrointestinal (GI) symptoms. AIM: To unravel the mechanisms underlying FODMAP-induced symptom reporting, we investigated gut and brain responses to fructan administration in IBS patients and HC. METHODS: This randomised, double-blind, cross-over study consisted of three visits where fructans (40 g/500 mL saline), glucose (40 g/500 mL saline) or saline (500 mL) were infused intragastrically during 1 h MR brain scanning; abdominal MRI was performed before, 1 h, and 2 h post-infusion. Symptoms were rated using validated scales. RESULTS: In IBS (n = 13), fructans induced more cramps, pain, flatulence and nausea compared to glucose (P = 0.03, 0.001, 0.009 and <0.001 respectively), contrary to HC (n = 13) (all P > 0.14), with between-group differences for cramps and nausea (P = 0.004 and 0.023). Fructans increased small bowel motility and ascending colonic gas and volume equally in IBS and HC (between-group P > 0.25). The difference in colonic gas between fructans and saline covaried with differences in bloating and cramps in IBS (P = 0.008 and 0.035 respectively). Pain-related brain regions responded differentially to fructans in IBS compared to HC, including the cerebellum, supramarginal gyrus, anterior and midcingulate cortex, insula and thalamus (pFWE-corrected < 0.05); these brain responses covaried with symptom responses in IBS. CONCLUSIONS: Fructans increase small bowel motility and colon gas and volume similarly in IBS patients and HC. Increased symptom responses to fructans in IBS covary with altered brain responses in pain-related regions, indicating that gut-brain axis dysregulation may drive FODMAP-induced symptom generation in IBS.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wu J, Masuy I, Biesiekierski JR, et al. Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome. Aliment Pharmacol Ther. 2022. PMID: 35166384. doi:10.1111/apt.16812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。